Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

Curaleaf Hldgs Inc. (CURLF)

  • Business News
  • June 03, 2026, 11:45 UTC
  • 4
  • 1 comments

Curaleaf Confirms Effective Date of Reverse Stock Split

Market reaction Comment Full text

DOCGO INC. (DCGO)

  • Business News
  • June 03, 2026, 11:35 UTC
  • 6
  • 1 comments

DocGo Launches Mobile Phlebotomy Services in South Florida

Market reaction Comment Full text

GANNETT CO., INC. (TDAY)

  • Business News
  • June 03, 2026, 11:30 UTC
  • 3
  • 1 comments

USA TODAY Co. to Present at the Rosenblatt 6th Annual Technology Summit: The Age of AI

Market reaction Comment Full text

GIBRALTAR INDUSTRIES, INC. (ROCK)

  • Business News
  • June 03, 2026, 11:30 UTC
  • 3
  • 1 comments

Gibraltar to Attend Wells Fargo 16th Industrials & Materials Conference

Market reaction Comment Full text

DYNE THERAPEUTICS, INC. (DYN)

  • Business News
  • June 03, 2026, 11:30 UTC
  • 6
  • 1 comments

Dyne Therapeutics Announces Completion of Enrollment in Registrational Expansion Cohort of ACHIEVE Trial of Z-Basivarsen for Myotonic Dystrophy Type 1 (DM1)

Market reaction Comment Full text

BREAD FINANCIAL HOLDINGS, INC. (BFH)

  • Business News
  • June 03, 2026, 11:30 UTC
  • 4
  • 1 comments

Bread Financial to Participate in the Morgan Stanley US Financials Conference

Market reaction Comment Full text

TG THERAPEUTICS, INC. (TGTX)

  • Business News
  • June 03, 2026, 11:30 UTC
  • 5
  • 1 comments

TG Therapeutics Announces Positive Results from Phase 1 Trial Evaluating Subcutaneous BRIUMVI® (ublituximab-xiiy)

Market reaction Comment Full text

V2X, INC. (VVX)

  • Business News
  • June 03, 2026, 11:30 UTC
  • 5
  • 1 comments

V2X to Generate Interest Expense Savings Through Successful Term Loan Repricing

Market reaction Comment Full text

BIOGEN INC. (BIIB)

  • Business News
  • June 03, 2026, 11:30 UTC
  • 6
  • 1 comments

Biogen Announces Upcoming Kidney Presentations at European Renal Association and American Transplant Congresses

Market reaction Comment Full text

PALVELLA THERAPEUTICS, INC. (PVLA)

  • Business News
  • June 03, 2026, 11:30 UTC
  • 5
  • 1 comments

Palvella Therapeutics Announces Completion of FDA Pre-NDA Meeting for QTORIN™ Rapamycin in Microcystic Lymphatic Malformations

Market reaction Comment Full text
  • Previous
  • 1444
  • 1445
  • 1446
  • 1447
  • 1448
  • Next

Search

News categories

  • Technical Exchange News(13517)
  • Event(6229)
  • SEC News(351105)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(192883)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin